RecallHawk
Class II Recall

Cooling Menthol Extra Strength Pain Relief Patch, Menthol 7.5%, packaged in box of 5, Distributed by J.R. Watkins LLC, O

JR Watkins

Summary

The FDA issued a Class II for Cooling Menthol Extra Strength Pain Relief Patch, Menthol 7.5%, packaged in box by JR Watkins. Reason: cGMP Deviations.

Details

Source

Drug Recall

External ID

D-0075-2025

Action Date

2024-12-04

Status

Terminated

Category

drug

Product Description

Cooling Menthol Extra Strength Pain Relief Patch, Menthol 7.5%, packaged in box of 5, Distributed by J.R. Watkins LLC, Oakland CA 94612 UPC 8 56294 00878 5, NDC 72342-100-05

Lot/Code Info: Lot # JC101, JC102 and JC103, exp. date Oct 31, 2025

Quantity Affected: 7,138 patches

Reason for Recall

cGMP Deviations

Distribution

Nationwide in the US

Type: Voluntary: Firm initiated

Recall Initiated: 2024-11-01

Company

JR Watkins

Bristol, PA

Context & Analysis

This is a Class II recall. Class II recalls indicate that use of or exposure to the product may cause temporary or medically reversible health consequences, or that the probability of serious consequences is remote.

This was one of 55 drug recalls issued in the same week, part of 267 drug-related FDA actions this month.

Frequently Asked Questions

What is a Class II recall?

A Class II recall means the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. Consumers should discontinue use.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (JR Watkins) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does JR Watkins have FDA actions?

This is the only FDA action we have on record for JR Watkins in our database.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "D-0075-2025" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions